FDA looks to simplify drug info packets
NEW YORK — The Food and Drug Administration is working on creating new and simplified drug information sheets for consumers to replace the multipage and sometimes labyrinthine packets supplied with drugs at retail pharmacies, according to published reports.
The Wall Street Journal reported that the agency was testing the information sheets while the U.S. Pharmacopeia Convention was developing a new standard for drug labels.
The large inserts — called consumer medication information, or CMI — that accompany drugs have long been cited as a problem for consumers because of their tiny print and the confusing way they present drug indications, guidelines and warnings.
In 2008, the FDA conducted a study that found that while 94% of shoppers received CMI with their prescriptions, about 75% of CMI met the “minimum criteria for usefulness,” a number that the agency said fell short of its goal of having 95% of prescriptions accompanied by useful CMI by 2006.
Wolters Kluwer to acquire Lexi-Comp
PHILADELPHIA — Market research firm Wolters Kluwer Health will acquire drug information provider Lexi-Comp, Wolters Kluwer said Wednesday. Financial terms of the deal were not disclosed.
Wolters Kluwer already had a relationship with Lexi-Comp through the former’s UpToDate business, which provides electronic clinical information through the Internet and mobile devices to more than 400,000 clinicians and other users. Lexi-Comp, based in Cleveland, provides drug information and medical reference content to more than 1,500 hospitals around the world and publishes drug monographs on more than 1,700 products.
Wolters Kluwer said the acquisition would strengthen its position in the clinical decision support and point-of-care segments and provide customers with more robust drug information and clinical content, allowing pharmacists, nurses and physicians to use an extended suite of mobile capabilities and online platforms.
Price Chopper brings APhA’s Project Impact: Diabetes initiative to stores
SCHENECTADY, N.Y. — Northeast supermarket chain Price Chopper will expand several of its health-and-wellness programs to combat diabetes as part of its participation in the American Pharmacists Association Foundation’s Project Impact: Diabetes initiative, the chain said.
The multiyear initiative, which the APhA Foundation announced last month, is designed to improve care for people across the country affected by diabetes. For its part, Price Chopper will expand its Diabetes AdvantEdge HealthyU Diabetes Education program and the NuVal nutrition ranking system under a partnership with the Capital District Physician’s Health Plan. Of the 25 companies nationwide participating, Price Chopper, which operates 128 stores in New York, Pennsylvania and New England, is the only one in New York.
“Diabetes care is a priority at Price Chopper,” Price Chopper VP pharmacy Vincent Mainella said. “We recognize that our stores are a bona fide destination for patients seeking the prescriptions, accessories, fresh foods and nutritional information needed to help them manage their diabetes.”